Avita Medical
RCEL
61 hedge funds and large institutions have $137M invested in Avita Medical in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 12 closing their positions.
77% more capital invested
Capital invested by funds: $77.4M → $137M (+$59.9M)
75% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 12
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
17% more funds holding
Funds holding: 52 → 61 (+9)
11.08% more ownership
Funds ownership: 16.72% → 27.81% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
99% less call options, than puts
Call options by funds: $11K | Put options by funds: $1.25M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$18.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.8M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$8.92M |
| 4 |
RI
RTW Investments
New York
|
+$6.51M |
| 5 |
Millennium Management
New York
|
+$4.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$3.06M |
| 2 |
AAMU
AEGON Asset Management (UK)
Edinburgh,
United Kingdom
|
-$2.57M |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$1.53M |
| 4 |
CC
Clearline Capital
New York
|
-$1.19M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$941K |
RCEL Hedge Fund Activity: Q1 2021 in Review
61 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q1 2021, worth a combined $137M — up 77% from $77.4M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new RCEL positions and 12 closed out — a net gain of 9 holders — while 17 added to existing stakes and 10 trimmed.
The largest buyer was Farallon Capital Management, opening a new position worth an estimated $18.6M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $3.06M sold.
- 61 institutional investors held Avita Medical (RCEL) as of Q1 2021, up from 52 in Q4 2020.
- Funds reported $137M of Avita Medical stock for Q1 2021, up 77% quarter-over-quarter.
- 21 funds opened new Avita Medical positions in Q1 2021 and 12 closed out, a net change of +9 holders.
- The largest Avita Medical buyer in Q1 2021 was Farallon Capital Management, an estimated $18.6M added.
- The largest Avita Medical seller in Q1 2021 was Renaissance Technologies, an estimated $3.06M sold.
Based on aggregated 13F filings for Q1 2021.